Human serum thyrotrophin measurement by ultrasensitive immunoradiometric assay as a first-line test in the evaluation of thyroid function. 1986

E Martino, and G Bambini, and L Bartalena, and C Mammoli, and F Aghini-Lombardi, and L Baschieri, and A Pinchera

An ultrasensitive immunoradiometric assay (IRMA) using two monoclonal anti-TSH antibodies has been used for TSH measurements in basal conditions and after TRH stimulation. The results have been compared with those obtained by conventional radioimmunoassay (RIA). The IRMA method had very high sensitivity (0.07 microU/ml). Detectable serum TSH concentrations were found in all normal subjects by IRMA, but in only 76% by RIA. No overlap was observed with the results obtained by IRMA in untreated overtly hyperthyroid patients, in whom serum TSH was below the limit of detection. The relationship between basal and TRH-stimulated serum TSH concentrations by IRMA and RIA was evaluated in 176 subjects including normals and patients with untreated and treated hyperthyroidism, functioning thyroid adenoma, nontoxic goitre and patients on L-thyroxine therapy. A normal TSH response to TRH was observed in virtually all patients with detectable basal serum TSH by both methods. When patients with undetectable basal serum TSH levels were considered, all but one (98%) had no TSH response to TRH by IRMA. On the contrary using RIA, an absent response was found only in 47% of subjects, a blunted responses in 10% and a normal response in 42%. These data indicate that basal serum TSH measurements by IRMA allows a complete discrimination of normal from hyperthyroid patients and can avoid the need for TRH stimulation tests.

UI MeSH Term Description Entries
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006042 Goiter Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC). Goiters
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

E Martino, and G Bambini, and L Bartalena, and C Mammoli, and F Aghini-Lombardi, and L Baschieri, and A Pinchera
April 1986, Clinical chemistry,
E Martino, and G Bambini, and L Bartalena, and C Mammoli, and F Aghini-Lombardi, and L Baschieri, and A Pinchera
September 1987, Clinica chimica acta; international journal of clinical chemistry,
E Martino, and G Bambini, and L Bartalena, and C Mammoli, and F Aghini-Lombardi, and L Baschieri, and A Pinchera
March 1987, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
E Martino, and G Bambini, and L Bartalena, and C Mammoli, and F Aghini-Lombardi, and L Baschieri, and A Pinchera
May 1987, Scandinavian journal of clinical and laboratory investigation,
E Martino, and G Bambini, and L Bartalena, and C Mammoli, and F Aghini-Lombardi, and L Baschieri, and A Pinchera
April 1986, Journal of endocrinological investigation,
E Martino, and G Bambini, and L Bartalena, and C Mammoli, and F Aghini-Lombardi, and L Baschieri, and A Pinchera
November 1984, British medical journal (Clinical research ed.),
E Martino, and G Bambini, and L Bartalena, and C Mammoli, and F Aghini-Lombardi, and L Baschieri, and A Pinchera
July 1988, Clinical chemistry,
E Martino, and G Bambini, and L Bartalena, and C Mammoli, and F Aghini-Lombardi, and L Baschieri, and A Pinchera
July 1971, Lancet (London, England),
E Martino, and G Bambini, and L Bartalena, and C Mammoli, and F Aghini-Lombardi, and L Baschieri, and A Pinchera
February 1985, Lancet (London, England),
E Martino, and G Bambini, and L Bartalena, and C Mammoli, and F Aghini-Lombardi, and L Baschieri, and A Pinchera
November 1987, Annals of clinical biochemistry,
Copied contents to your clipboard!